Penumbra, Inc. announced 90-day results of the STORM-PE randomized controlled trial (RCT) that is evaluating computer-assisted va ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD –– Results from Phase 3 study of ...
Penumbra (NYSE:PEN) today announced 90-day results from the landmark STORM-PE randomized trial of its thrombectomy technology ...
Rademikibart administered as a single 300 mg 2-minute IV push to asthma and chronic obstructive pulmonary disease (COPD) patients produced ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities ...
Key points A 69-year-old man presented to a dermatology clinic with a 1-day history of a painful erythematous rash. Four days ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Despite advances in diagnosis and treatment, PE continues to place a significant burden on patients and health systems worldwide; at least 400,000 hospitalizations in the US are annually as a result ...
Outcomes for PE are better with ultrasound-facilitated, catheter-directed fibrinolysis plus anticoagulation vs anticoagulation alone.
The burden of RSV-associated hospitalization was high in older adults, with the greatest risk among the oldest age strata and those with CHF.
Pulmonary embolism, or PE, is a serious and sometimes life-threatening condition that occurs when a blood clot travels to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results